ALT
Altimmune, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.25
+0.31%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- -$0.14
- Revenue estimate
- $1.8K
Latest reported
- Last report date
- Aug 12, 2026
- EPS actual
- -$0.12
- EPS estimate
- -$0.14
- Revenue actual
- —
- Revenue estimate
- $2.0K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 11
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +12.9%
- Revenue beats (12Q)
- 6
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 12, 2026 | -$0.14 | -$0.12 | Beat 11.44% | — |
| May 13, 2026 | -$0.25 | -$0.18 | Beat 28.00% | — |
| Mar 5, 2026 | -$0.23 | -$0.27 | Miss -15.38% | $26.0K |
| Nov 6, 2025 | -$0.29 | -$0.21 | Beat 27.59% | $5.0K |
| Aug 12, 2025 | -$0.32 | -$0.27 | Beat 15.62% | $5.0K |
| Feb 27, 2025 | -$0.34 | -$0.33 | Beat 2.94% | $5.0K |
| May 9, 2024 | -$0.36 | -$0.34 | Beat 5.56% | $5.0K |
| Aug 10, 2023 | -$0.44 | -$0.32 | Beat 27.27% | $6.0K |
| May 11, 2023 | -$0.49 | -$0.40 | Beat 18.37% | $21.0K |
| Feb 28, 2023 | -$0.52 | -$0.43 | Beat 17.31% | $110.0K |
| Nov 10, 2022 | -$0.49 | -$0.48 | Beat 2.04% | — |
| Aug 11, 2022 | -$0.45 | -$0.42 | Beat 6.67% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026